Trials / Completed
CompletedNCT04456621
Proton Beam Therapy for Unresectable Liver Metastasis
Proton Beam Radiotherapy for Unresectable Liver Metastasis: Prospective Phase II Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The investigators performed the present study to evaluate the role of proton beam therapy for liver metastasis which is unresectable and unsuitable for radiofrequency ablation (RFA) in terms of local control and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | PBT | Proton beam radiotherapy 70 gray relative biological equivalent (GyRBE)/10 fractions (Fx) or 60 GyRBE/5 Fx |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-06-30
- Completion
- 2021-07-31
- First posted
- 2020-07-02
- Last updated
- 2023-11-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04456621. Inclusion in this directory is not an endorsement.